ACP
ANGO icon

Acuta Capital Partners’s AngioDynamics ANGO Stock Holding History

Acuta Capital Partners’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10,000
Closed -$178K – 52
2015
Q1 		$178K Buy
+10,000
New +$186K 0.15% 50

Other funds holding ANGO

RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FMA
Fiduciary Management Associates Chicago, Illinois $1.53B AUM 4.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Acuta Capital Partners's ANGO Position: Q2 2015 in Review

Acuta Capital Partners sold out of AngioDynamics (ANGO) in Q2 2015, closing a stake of 10,000 shares — an estimated $178K sold.

Acuta Capital Partners first reported a position in ANGO in Q1 2015 and held it in 1 quarter. The position peaked at $178K in Q1 2015. 116 funds tracked by Wall St. Rank hold ANGO as of Q2 2015.

  • Acuta Capital Partners reported no remaining AngioDynamics position as of Q2 2015 after selling out during the quarter.
  • Acuta Capital Partners sold 10,000 AngioDynamics shares in Q2 2015, an estimated $178K.
  • Acuta Capital Partners first reported a position in AngioDynamics in Q1 2015 and held it in 1 quarter.
  • Acuta Capital Partners's AngioDynamics position peaked at $178K in Q1 2015.
  • 116 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2015.

Based on Acuta Capital Partners's 13F filing for Q2 2015, filed 14 Aug 2015.